Andy Nguyen

Andy Nguyen is currently serving as the Senior Director of Global Commercial and Market Access Strategy at Sumitomo Pharma America, Inc., where responsibilities include leading commercial strategies for the rare disease franchise. Prior to this role, Andy held the position of Director of Market Access for Rare Disease at Enzyvant and served as the Associate Director of Global Health Economics and Outcomes Research at Global Blood Therapeutics. Andy's career in health economics began with multiple roles, including Senior Manager at BluePath Solutions and Research Assistant at the Leonard D. Schaeffer Center for Health Policy and Economics. Andy holds a Ph.D. in Health Economics and Policy from the University of Southern California and a Bachelor's degree in Economics from Loyola Marymount University.